Related Experiment Videos
Chemotherapy for older women with node-positive breast cancer
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
DOSE DEPENDENCE OF RADIATION INDUCED DAMAGE IN THE THERMOLUMINESCENT RESPONSE OF LIF:Mg,Ti (TLD-100).
Radiation protection dosimetry·2020
Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
Journal of thrombosis and haemostasis : JTH·2016
The molecular biology of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia·2013
Factors influencing tissue nitrate concentration in field-grown wild rocket (Diplotaxis tenuifolia) in southern England.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2012
The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model.
Journal of thrombosis and haemostasis : JTH·2011
Molecular and cellular biology of von Willebrand factor.
Trends in cardiovascular medicine·2011
"Our blood is not pure enough": a qualitative study to understand systemic racial barriers to blood donation for Black people in Canada.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Experiences of culturally Deaf people with health care access and navigation in Ontario, Canada: a qualitative co-design study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026